Document is current
Any future updates will be listed below
-
Authors
Bozkaya, Duygu
Zou, Heng
Lu, Cindy
Tsao, Nicole W.
Lam, Byron L.
- License Information
-
More Information
Article History
Received: 21 September 2021
Accepted: 30 December 2021
First Online: 16 January 2022
Declarations
:
: Not applicable.
: Not applicable.
: DB, HZ, and CL are employees of Biogen and may hold stock in the company. NWT is an employee of Sanofi Genzyme and was an employee of Biogen at the time of the study and may hold stock in the company. BLL has served as a consultant for Biogen and ProQR Therapeutics and has received research and clinical trial funding from Applied Genetic Technologies Corporation, Biogen, Editas Medicine, National Eye Institute, Pixium Vision, and ProQR Therapeutics.
